Page last updated: 2024-11-07

estrone and Long Sleeper Syndrome

estrone has been researched along with Long Sleeper Syndrome in 6 studies

Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to describe the changes in symptom interference during the menopausal transition (MT) stages and early postmenopause (PM), including the effects of age, MT-related factors (estrone, follicle-stimulating hormone, testosterone, MT stages), symptoms (hot flashes, depressed mood, awakening during the night, anxiety, backache, joint pain, forgetfulness, and difficulty concentrating), health-related factors (perceived health), and stress-related factors (perceived stress, cortisol)."3.77Symptom interference with work and relationships during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. ( Mitchell, ES; Woods, NF, 2011)
"To determine whether hot flashes, depressed mood, sleep, cognitive and sexual symptoms correlate with urinary follicle-stimulating hormone (FSH), estrone (E(1)G), and testosterone (T) and with each other during the menopausal transition and early postmenopause (PM)."3.74Symptoms during the menopausal transition and early postmenopause and their relation to endocrine levels over time: observations from the Seattle Midlife Women's Health Study. ( Mitchell, ES; Percival, DB; Smith-Dijulio, K; Tao, EY; Taylor, HJ; Woods, NF, 2007)
"We recruited 177 post-menopausal women to register hot flashes, vaginal dryness, depression, anxiety, sleep alterations, and serum hormones (FSH, LH, estrone, and estradiol)."3.72The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in post-menopausal women. ( Malacara, JM; Martínez-Garza, S; Pérez-Luque, EL; Sánchez-Marín, FJ, 2004)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Joffe, H1
Crawford, S1
Economou, N1
Kim, S1
Regan, S1
Hall, JE1
White, D1
Woods, NF3
Cray, L1
Mitchell, ES3
Herting, JR1
Kische, H1
Ewert, R1
Fietze, I1
Gross, S1
Wallaschofski, H1
Völzke, H1
Dörr, M1
Nauck, M1
Obst, A1
Stubbe, B1
Penzel, T1
Haring, R1
Malacara, JM1
Pérez-Luque, EL1
Martínez-Garza, S1
Sánchez-Marín, FJ1
Smith-Dijulio, K1
Percival, DB1
Tao, EY1
Taylor, HJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Impact of Experimentally Induced Hot Flashes on Sleep and Mood Disturbance[NCT01116401]Phase 429 participants (Actual)Interventional2009-11-03Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change in Montgomery-Asperg Depression Rating Scale (MADRS)

The Montgomery-Åsberg Depression Rating Scale is a widely used 10-item clinician-rated scale that describes the severity of depressive symptoms. It has a range of 0-60 with higher scores indicating greater symptom burden. Participants were assessed at baseline and four weeks after the GnRHa injection in order to calculate the change in MADRS score. (NCT01116401)
Timeframe: baseline and 4 weeks

Interventionunits on a scale (Mean)
GnRH Agonist Injection3.1

Percent Change in Wake After Sleep Onset (WASO)

Wake after sleep onset (WASO) is calculated by averaging the number of minutes spent awake after initiating sleep each night from the two ambulatory polysomnography studies conducted at baseline and the two ambulatory polysomnography studies conducted four weeks after the GnRHa injection. (NCT01116401)
Timeframe: baseline and 4 weeks

Interventionpercent change (Number)
GnRH Agonist Injection62

Other Studies

6 other studies available for estrone and Long Sleeper Syndrome

ArticleYear
A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep.
    Sleep, 2013, Dec-01, Volume: 36, Issue:12

    Topics: Adolescent; Adult; Circadian Rhythm; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonad

2013
Endocrine biomarkers and symptom clusters during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.
    Menopause (New York, N.Y.), 2014, Volume: 21, Issue:6

    Topics: Adult; Affective Symptoms; Autonomic Nervous System; Cognition Disorders; Estrone; Female; Follicle

2014
Sex Hormones and Sleep in Men and Women From the General Population: A Cross-Sectional Observational Study.
    The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:11

    Topics: Adult; Age Factors; Algorithms; Androstenedione; Cohort Studies; Cross-Sectional Studies; Dehydroepi

2016
Symptom interference with work and relationships during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study.
    Menopause (New York, N.Y.), 2011, Volume: 18, Issue:6

    Topics: Adult; Anxiety; Biomarkers; Comorbidity; Depression; Estrone; Female; Follicle Stimulating Hormone,

2011
The relationship of estrogen receptor-alpha polymorphism with symptoms and other characteristics in post-menopausal women.
    Maturitas, 2004, Oct-15, Volume: 49, Issue:2

    Topics: Anxiety; Bone Density; Cross-Sectional Studies; Depression; Educational Status; Estradiol; Estrogen

2004
Symptoms during the menopausal transition and early postmenopause and their relation to endocrine levels over time: observations from the Seattle Midlife Women's Health Study.
    Journal of women's health (2002), 2007, Volume: 16, Issue:5

    Topics: Adult; Anxiety; Biomarkers; Depression; Estrone; Female; Follicle Stimulating Hormone, Human; Health

2007